Dr. Gene G. Finley
Claim this profileAllegheny General Hospital
Studies Colon Cancer
Studies Lung Cancer
12 reported clinical trials
41 drugs studied
Area of expertise
1Colon Cancer
Stage III
Stage IV
MLH1 positive
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Gene G. Finley is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy + Atezolizumab
for Small Cell Lung Cancer
This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of the body (extensive stage). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving radiation therapy in addition to atezolizumab may extend the time without extensive small cell lung cancer growing or spreading compared to atezolizumab alone.
Recruiting1 award Phase 2 & 311 criteria
More about Gene G. Finley
Clinical Trial Related11 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gene G. Finley has experience with
- Atezolizumab
- Nivolumab
- Relatlimab
- Tucatinib
- Trastuzumab
- Durvalumab
Breakdown of trials Gene G. Finley has run
Colon Cancer
Lung Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gene G. Finley specialize in?
Gene G. Finley focuses on Colon Cancer and Lung Cancer. In particular, much of their work with Colon Cancer has involved Stage III patients, or patients who are Stage IV.
Is Gene G. Finley currently recruiting for clinical trials?
Yes, Gene G. Finley is currently recruiting for 2 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Gene G. Finley has studied deeply?
Yes, Gene G. Finley has studied treatments such as Atezolizumab, Nivolumab, Relatlimab.
What is the best way to schedule an appointment with Gene G. Finley?
Apply for one of the trials that Gene G. Finley is conducting.
What is the office address of Gene G. Finley?
The office of Gene G. Finley is located at: Allegheny General Hospital, Pittsburgh, Pennsylvania 15212 United States. This is the address for their practice at the Allegheny General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.